Evidence map›Paper›PMID 32005542›Full record

ArticleThe Journal of pediatrics2020

Circumstances Involved in Unsupervised Solid Dose Medication Exposures among Young Children.

Maneesha Agarwal, Maribeth C Lovegrove, Robert J Geller, Adam C Pomerleau, Mathew R P Sapiano, Nina J Weidle, Brent W Morgan, Daniel S Budnitz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Toxidromes.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Reply.The Journal of pediatrics · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maneesha AgarwalDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
Maribeth C LovegroveDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Robert J GellerDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA.
Adam C PomerleauDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
Mathew R P SapianoDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Nina J WeidleEagle Global Scientific, LLC, Atlanta, GA.
Brent W MorganDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA.
Daniel S BudnitzDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Emory University · USCenters for Disease Control and Prevention · USEagle Mount · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo identify types of containers from which young children accessed solid dose medications (SDMs) during unsupervised medication exposures and the intended recipients of the medications to advance prevention. STUDY

designFrom February to September 2017, 5 US poison centers enrolled individuals calling about unsupervised solid dose medication exposures by children ≤5 years. Study participants answered contextually directed questions about exposure circumstances.

resultsSixty-two percent of eligible callers participated. Among 4496 participants, 71.6% of SDM exposures involved children aged ≤2 years; 33.8% involved only prescription medications, 32.8% involved only over-the-counter (OTC) products that require child-resistant packaging, and 29.9% involved ≥1 OTC product that does not require child-resistant packaging. More than one-half of exposures (51.5%) involving prescription medications involved children accessing medications that had previously been removed from original packaging, compared with 20.8% of exposures involving OTC products (aOR, 3.39; 95% CI, 2.87-4.00). Attention deficit hyperactivity disorder medications (49.3%) and opioids (42.6%) were often not in any container when accessed; anticonvulsants (41.1%), hypoglycemic agents (33.8%), and cardiovascular/antithrombotic agents (30.8%) were often transferred to alternate containers. Grandparents' medications were involved in 30.7% of prescription medication exposures, but only 7.8% of OTC product exposures (aOR, 3.99; 95% CI, 3.26-4.87).

conclusionsEfforts to reduce pediatric SDM exposures should also address exposures in which adults, rather than children, remove medications from child-resistant packaging. Packaging/storage innovations designed to encourage adults to keep products within child-resistant packaging and specific educational messages could be targeted based on common exposure circumstances, medication classes, and medication intended recipients.

Indexed as

Drug PackagingChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMaleNonprescription DrugsPrescription DrugsProspective StudiesNonprescription DrugsPrescription Drugsdrug packagingmedication ingestionmedication safetypediatric poisoningpoison preventionunit-dose packaging

Identifiers

PMID32005542
PMCPMC10935586
OpenAlexW3004371803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.